Quick Summary:
In the rapidly evolving Bovine Respiratory Disease Treatment market, there is an essential need to stay abreast of the current trends and future directions of the industry. Our new market research report estimates the global market size at US$2.1 Billion in 2022, with projections to reach a staggering US$3.4 Billion by 2030. This offering provides unmatched depth, breadth, and quality of data, illuminating the path to strategic decision-making in this competitive sector.
Notably, different segments in this industry, such as Vaccines and Antibiotics, record significant growth rates and this report delves deeper into these aspects. Essential information on notable markets like the U.S, China, Japan, Canada, and Germany, complete with their forecasts, form part of this comprehensive study. At the same time detailed insights about top competitors like Bayer AG, Bimeda Group, Elanco and others are a highlight. Our cutting-edge research platform and inclusive range of bespoke updates, further augment the utility of this report for global industry executives. Be a part of this evolving market story by purchasing our exclusive market research report.
Global Bovine Respiratory Disease Treatment Market to Reach $3.4 Billion by 2030
The global market for Bovine Respiratory Disease Treatment estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$3.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2022-2030. Vaccines, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Antibiotics segment is readjusted to a revised 6.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $547.9 Million, While China is Forecast to Grow at 9.8% CAGR
The Bovine Respiratory Disease Treatment market in the U.S. is estimated at US$547.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$808.1 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Select Competitors (Total 12 Featured) -
- Bayer AG
- Bimeda Group
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco
- Merck & Co., Inc.
- Vetoquinol S.A.
- Virbac Group
- Zoetis Services LLC
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Frequently Asked Questions about the Global Market for Bovine Respiratory Disease Treatment
What is the estimated value of the Global Market for Bovine Respiratory Disease Treatment?
The Global Market for Bovine Respiratory Disease Treatment was estimated to be valued at $2.1 Billion in 2022.
What is the growth rate of the Global Market for Bovine Respiratory Disease Treatment?
The growth rate of the Global Market for Bovine Respiratory Disease Treatment is 6.2%, with an estimated value of $3.4 Billion by 2030.
What is the forecasted size of the Global Market for Bovine Respiratory Disease Treatment?
The Global Market for Bovine Respiratory Disease Treatment is estimated to be worth $3.4 Billion by 2030.
Who are the key companies in the Global Market for Bovine Respiratory Disease Treatment?
Key companies in the Global Market for Bovine Respiratory Disease Treatment include Bayer AG, Bimeda Group, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco, Merck & Co., Inc., Vetoquinol S.A., Virbac Group and Zoetis Services LLC.
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.1 Billion |
| Forecasted Market Value ( USD | $ 3.4 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Bovine Respiratory Disease Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Bovine Respiratory Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Bovine Respiratory Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 13: World Bovine Respiratory Disease Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- Table 14: World Recent Past, Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 15: World Historic Review for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 16: World 16-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
UNITED STATES
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 17: USA Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 18: USA Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 19: USA 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
CANADA
- Table 20: Canada Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 21: Canada Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 22: Canada 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
JAPAN
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 23: Japan Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: Japan Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 25: Japan 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
CHINA
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 26: China Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 27: China Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 28: China 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
EUROPE
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 29: Europe Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 30: Europe Historic Review for Bovine Respiratory Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 31: Europe 16-Year Perspective for Bovine Respiratory Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 32: Europe Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: Europe Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 34: Europe 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
FRANCE
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 35: France Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: France Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 37: France 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
GERMANY
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 38: Germany Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: Germany Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 40: Germany 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
ITALY
- Table 41: Italy Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 42: Italy Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 43: Italy 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 44: UK Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 45: UK Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 46: UK 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
SPAIN
- Table 47: Spain Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 48: Spain Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 49: Spain 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
RUSSIA
- Table 50: Russia Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: Russia Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 52: Russia 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 53: Rest of Europe Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 54: Rest of Europe Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 55: Rest of Europe 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 57: Asia-Pacific Historic Review for Bovine Respiratory Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 58: Asia-Pacific 16-Year Perspective for Bovine Respiratory Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: Asia-Pacific Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 61: Asia-Pacific 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
AUSTRALIA
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- Table 62: Australia Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: Australia Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 64: Australia 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
INDIA
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- Table 65: India Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: India Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 67: India 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
SOUTH KOREA
- Table 68: South Korea Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: South Korea Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 70: South Korea 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
- Table 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 72: Rest of Asia-Pacific Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 73: Rest of Asia-Pacific 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
LATIN AMERICA
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- Table 74: Latin America Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 75: Latin America Historic Review for Bovine Respiratory Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 76: Latin America 16-Year Perspective for Bovine Respiratory Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
- Table 77: Latin America Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: Latin America Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 79: Latin America 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
ARGENTINA
- Table 80: Argentina Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Argentina Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 82: Argentina 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
BRAZIL
- Table 83: Brazil Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Brazil Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 85: Brazil 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
MEXICO
- Table 86: Mexico Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Mexico Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 88: Mexico 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
REST OF LATIN AMERICA
- Table 89: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 90: Rest of Latin America Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 91: Rest of Latin America 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
MIDDLE EAST
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- Table 92: Middle East Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 93: Middle East Historic Review for Bovine Respiratory Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 94: Middle East 16-Year Perspective for Bovine Respiratory Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
- Table 95: Middle East Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 96: Middle East Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 97: Middle East 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
IRAN
- Table 98: Iran Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 99: Iran Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 100: Iran 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
ISRAEL
- Table 101: Israel Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 102: Israel Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 103: Israel 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
SAUDI ARABIA
- Table 104: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 105: Saudi Arabia Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 106: Saudi Arabia 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
UNITED ARAB EMIRATES
- Table 107: UAE Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 108: UAE Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 109: UAE 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
REST OF MIDDLE EAST
- Table 110: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 111: Rest of Middle East Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 112: Rest of Middle East 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
AFRICA
- Bovine Respiratory Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- Table 113: Africa Recent Past, Current & Future Analysis for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 114: Africa Historic Review for Bovine Respiratory Disease Treatment by Segment - Vaccines, Antibiotics, NSAIDs and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 115: Africa 16-Year Perspective for Bovine Respiratory Disease Treatment by Segment - Percentage Breakdown of Value Sales for Vaccines, Antibiotics, NSAIDs and Other Segments for the Years 2014, 2023 & 2030
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- Bimeda Group
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco
- Merck & Co., Inc.
- Vetoquinol S.A.
- Virbac Group
- Zoetis Services LLC
